U.S. Sen. Jim DeMint on the Human Cost of Health Care Reform

U.S. Sen. Jim DeMint (R-S.C.), one of the Heartland Institute’s
favorite legislators, puts Obama’s health care reforms in proper
perspective with this insightful op-ed that first ran in the Washington

By Sen. Jim DeMint

In Great Britain last year, a 24-year old woman named Katie Hilliard
was diagnosed with cervical cancer. The disease has since spread to her
lungs and lymph nodes.

In October, she took time off from her course of chemo and radiation
therapy to marry her fiancée because, in her words, “We didn’t know how
ill I would get.”

The family of Claire Everett does know. She died in September, of
the same disease, with her parents, husband, and two-year old son by
her side. She was 23.

Both could have been diagnosed early and possibly saved by a routine
screening test. But the British National Health Service does not allow
women under the age of 25 to receive that test.

These kinds of stories are commonplace in nations with
government-controlled health care, with good reason. As the miracle
workers in the global medical research field develop treatments to keep
us alive and healthy much longer than ever before, the costs of health
care inevitably rise. Government health services looking to cut costs
usually choose to ration coverage.

In Great Britain, Canada, Sweden, and elsewhere, government bureaucrats
decide which patients may receive which treatments based on how
beneficial the treatment will be – beneficial to the government, that
is, not the patient.



Popular Video